<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sukenikova L</submitter><funding>Charles University</funding><funding>Ministry of Education, Youth and Sport of the Czech Republic</funding><funding>Grant Agency of Charles University</funding><pagination>1624</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9140140</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(10)</volume><pubmed_abstract>Early postnatal events are important for the development of the neonatal immune system. Harboring the pioneering microorganisms forming the microbiota of the neonatal gastrointestinal tract is important for priming the immune system, as well as inducing appropriate tolerance to the relatively innocuous environmental antigens and compounds of normal healthy microbiota. Early postnatal supplementation of suitable, safe probiotics could accelerate this process. In the current study, the immunomodulatory capacity of the probiotic strain of &lt;i>Escherichia coli&lt;/i> O83:K24:H31 (EcO83) was characterized in vitro and in vivo. We compared the capacity of EcO83 with and without hemolytic activity on selected immune characteristics in vitro as determined by flow cytometry and quantitative real-time P</pubmed_abstract><journal>Cells</journal><pubmed_title>The Impact of &lt;i>Escherichia coli&lt;/i> Probiotic Strain O83:K24:H31 on the Maturation of Dendritic Cells and Immunoregulatory Functions In Vitro and In Vivo.</pubmed_title><pmcid>PMC9140140</pmcid><funding_grant_id>Cooperatio IMMU 207032</funding_grant_id><funding_grant_id>GAUK 478119</funding_grant_id><funding_grant_id>8J19AT010</funding_grant_id><funding_grant_id>Progres Q25/LF1</funding_grant_id><pubmed_authors>Petraskova P</pubmed_authors><pubmed_authors>Cerny V</pubmed_authors><pubmed_authors>Prokesova L</pubmed_authors><pubmed_authors>Vecek J</pubmed_authors><pubmed_authors>Novotna O</pubmed_authors><pubmed_authors>Vobruba S</pubmed_authors><pubmed_authors>Kolarova L</pubmed_authors><pubmed_authors>Sukenikova L</pubmed_authors><pubmed_authors>Michalcikova T</pubmed_authors><pubmed_authors>Hrdy J</pubmed_authors><pubmed_authors>Prochazka J</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Impact of &lt;i>Escherichia coli&lt;/i> Probiotic Strain O83:K24:H31 on the Maturation of Dendritic Cells and Immunoregulatory Functions In Vitro and In Vivo.</name><description>Early postnatal events are important for the development of the neonatal immune system. Harboring the pioneering microorganisms forming the microbiota of the neonatal gastrointestinal tract is important for priming the immune system, as well as inducing appropriate tolerance to the relatively innocuous environmental antigens and compounds of normal healthy microbiota. Early postnatal supplementation of suitable, safe probiotics could accelerate this process. In the current study, the immunomodulatory capacity of the probiotic strain of &lt;i>Escherichia coli&lt;/i> O83:K24:H31 (EcO83) was characterized in vitro and in vivo. We compared the capacity of EcO83 with and without hemolytic activity on selected immune characteristics in vitro as determined by flow cytometry and quantitative real-time P</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-26T02:51:19.519Z</modification><creation>2025-02-19T02:16:02.982Z</creation></dates><accession>S-EPMC9140140</accession><cross_references><pubmed>35626660</pubmed><doi>10.3390/cells11101624</doi></cross_references></HashMap>